Ledger.Open graph →
SEC Form D · filed January 5, 2021

Aro Biotherapeutics Co

Offering
$90.3M
Sold
$42.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Marten B. Steen · Philadelphia, PADirectorScott B. Greenberg · Philadelphia, PAExecSaan-Chirag B. Gandhi · Philadelphia, PADirectorChristopher B. Mirabelli · Philadelphia, PADirectorJess B. Lifton · Philadelphia, PADirectorElizabeth B. Anderson · Philadelphia, PADirectorKevin B. Raidy · Philadelphia, PADirectorMark B. Laurenzi · Philadelphia, PAExecSusan B. Dillon · Philadelphia, PAExec · DirectorKaryn B. O'Neil · Philadelphia, PAExec · DirectorBruce B. Peacock · Philadelphia, PADirectorJamie S. Haggard · Fort Collins, COExec · DirectorSteve S. Deitsch · Fort Collins, COExecCharles R. Conn · Oxford, United KingdomDirectorMichael A. Zercher · BUFFALO, NYDirectorRoger D. O'Brien · BUFFALO, NYDirectorKevin C. Smith · Denver, COExec · DirectorClifford B. Fleet · BUFFALO, NYDirectorSteven A. Przybyla · BUFFALO, NYDirectorJames A. Mish · BUFFALO, NYExecJohn A. Franzino · BUFFALO, NYDirectorMatthew S. Thompson · Fort Collins, CODirectorCraig Dickman · GREEN BAY, WIDirectorBob Vruggink · STEAMBOAT SPRINGS, COExecTyler Ellison · EGG HARBOR, WIExec · DirectorBill Butler · LOS ANGELES, CAExec · DirectorC. D. Adair · Nashville, TNDirectorHeidi Ridley · Orinda, CADirectorMaurcio Bustos · Orinda, CADirectorPatricia K. Salame · Oklahoma City, OKDirectorAlfredo Marti · Stamford, CTDirectorJoshua Goldberg · Baltimore, MDDirectorKenneth Ryan · Stamford, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗